Literature DB >> 16088366

Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.

Elizabeth T Golub1, Lisa A Purvis, Marcella Sapun, Mahboobeh Safaeian, Chris Beyrer, David Vlahov, Steffanie A Strathdee.   

Abstract

Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088366     DOI: 10.1007/s10461-005-9004-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  11 in total

1.  Factors associated with past research participation among low-income persons living with HIV.

Authors:  Jacquelyn Slomka; Georgios Kypriotakis; John Atkinson; Pamela M Diamond; Mark L Williams; Damon J Vidrine; Roberto Andrade; Roberto Arduino
Journal:  AIDS Patient Care STDS       Date:  2012-06-11       Impact factor: 5.078

2.  Enhancing HIV vaccine trial consent preparedness among street drug users.

Authors:  Celia B Fisher
Journal:  J Empir Res Hum Res Ethics       Date:  2010-06       Impact factor: 1.742

Review 3.  Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention.

Authors:  Shayesta Dhalla; Gary Poole
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Decisions to participate in research: views of underserved minority drug users with or at risk for HIV.

Authors:  Jacquelyn Slomka; Eric A Ratliff; Sheryl A McCurdy; Sandra Timpson; Mark L Williams
Journal:  AIDS Care       Date:  2008-11

5.  Willingness of Chinese injection drug users to participate in HIV vaccine trials.

Authors:  Lu Yin; Yuanzhi Zhang; Han-Zhu Qian; Baoling Rui; Lijiang Zhang; Junling Zhu; Yongsheng Guan; Yunxia Wang; Qingchun Li; Yuhua Ruan; Yiming Shao
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

6.  Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.

Authors:  Shayesta Dhalla; Gary Poole; Joel Singer; David M Patrick; Evan Wood; Thomas Kerr
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

7.  So different, yet so similar: meta-analysis and policy modeling of willingness to participate in clinical trials among Brazilians and Indians.

Authors:  Guilherme Zammar; Henrique Meister; Jatin Shah; Amruta Phadtare; Luciana Cofiel; Ricardo Pietrobon
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

8.  Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.

Authors:  M Florencia Etcheverry; Jennifer L Evans; Emilia Sanchez; Eva Mendez-Arancibia; Mercé Meroño; José M Gatell; Kimberly Page; Joan Joseph
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

9.  Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.

Authors:  Yuan Dong; Xiaoxing Shen; Ruizhang Guo; Baochi Liu; Lingyan Zhu; Jing Wang; Linxia Zhang; Jun Sun; Xiaoyan Zhang; Jianqing Xu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

10.  Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.

Authors:  Ali Mirzazadeh; Samira Hosseini-Hooshyar; Armita Shahesmaeili; Ali Bahramnejad; Adibeh Barshan; Ghazal Mousavian; Esmail Najafi; Hamid Sharifi; Ali-Akbar Haghdoost; Alya Briceno; Willi McFarland; Kimberly Page
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.